These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 27986919)

  • 1. Generation of inhibitory monoclonal antibodies targeting matrix metalloproteinase-14 by motif grafting and CDR optimization.
    Nam DH; Fang K; Rodriguez C; Lopez T; Ge X
    Protein Eng Des Sel; 2017 Feb; 30(2):113-118. PubMed ID: 27986919
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Generation of Highly Selective MMP Antibody Inhibitors.
    Nam DH; Ge X
    Methods Mol Biol; 2018; 1731():307-324. PubMed ID: 29318563
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Active-site MMP-selective antibody inhibitors discovered from convex paratope synthetic libraries.
    Nam DH; Rodriguez C; Remacle AG; Strongin AY; Ge X
    Proc Natl Acad Sci U S A; 2016 Dec; 113(52):14970-14975. PubMed ID: 27965386
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of highly selective MMP-14 inhibitory Fabs by deep sequencing.
    Lopez T; Nam DH; Kaihara E; Mustafa Z; Ge X
    Biotechnol Bioeng; 2017 Jun; 114(6):1140-1150. PubMed ID: 28090632
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selective function-blocking monoclonal human antibody highlights the important role of membrane type-1 matrix metalloproteinase (MT1-MMP) in metastasis.
    Remacle AG; Cieplak P; Nam DH; Shiryaev SA; Ge X; Strongin AY
    Oncotarget; 2017 Jan; 8(2):2781-2799. PubMed ID: 27835863
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epitope-specific affinity maturation improved stability of potent protease inhibitory antibodies.
    Lopez T; Chuan C; Ramirez A; Chen KE; Lorenson MY; Benitez C; Mustafa Z; Pham H; Sanchez R; Walker AM; Ge X
    Biotechnol Bioeng; 2018 Nov; 115(11):2673-2682. PubMed ID: 30102763
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Humanization of a murine monoclonal antibody by simultaneous optimization of framework and CDR residues.
    Wu H; Nie Y; Huse WD; Watkins JD
    J Mol Biol; 1999 Nov; 294(1):151-62. PubMed ID: 10556035
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Single-Framework Synthetic Antibody Library Containing a Combination of Canonical and Variable Complementarity-Determining Regions.
    Maruthachalam BV; El-Sayed A; Liu J; Sutherland AR; Hill W; Alam MK; Pastushok L; Fonge H; Barreto K; Geyer CR
    Chembiochem; 2017 Nov; 18(22):2247-2259. PubMed ID: 28884521
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Grafting of functional motifs onto protein scaffolds identified by PDB screening--an efficient route to design optimizable protein binders.
    Tlatli R; Nozach H; Collet G; Beau F; Vera L; Stura E; Dive V; Cuniasse P
    FEBS J; 2013 Jan; 280(1):139-59. PubMed ID: 23121732
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Affinity maturation of a novel antagonistic human monoclonal antibody with a long VH CDR3 targeting the Class A GPCR formyl-peptide receptor 1.
    Douthwaite JA; Sridharan S; Huntington C; Hammersley J; Marwood R; Hakulinen JK; Ek M; Sjögren T; Rider D; Privezentzev C; Seaman JC; Cariuk P; Knights V; Young J; Wilkinson T; Sleeman M; Finch DK; Lowe DC; Vaughan TJ
    MAbs; 2015; 7(1):152-66. PubMed ID: 25484051
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro affinity maturation of an anti-PSA antibody for prostate cancer diagnostic assay.
    Muller BH; Savatier A; L'Hostis G; Costa N; Bossus M; Michel S; Ott C; Becquart L; Ruffion A; Stura EA; Ducancel F
    J Mol Biol; 2011 Dec; 414(4):545-62. PubMed ID: 22019475
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Augmented Binary Substitution: Single-pass CDR germ-lining and stabilization of therapeutic antibodies.
    Townsend S; Fennell BJ; Apgar JR; Lambert M; McDonnell B; Grant J; Wade J; Franklin E; Foy N; Ní Shúilleabháin D; Fields C; Darmanin-Sheehan A; King A; Paulsen JE; Hickling TP; Tchistiakova L; Cunningham O; Finlay WJ
    Proc Natl Acad Sci U S A; 2015 Dec; 112(50):15354-9. PubMed ID: 26621728
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of a high-affinity human antibody with a disulfide bridge in the third complementarity-determining region of the heavy chain.
    Almagro JC; Raghunathan G; Beil E; Janecki DJ; Chen Q; Dinh T; LaCombe A; Connor J; Ware M; Kim PH; Swanson RV; Fransson J
    J Mol Recognit; 2012 Mar; 25(3):125-35. PubMed ID: 22407976
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SDR grafting--a new approach to antibody humanization.
    Kashmiri SV; De Pascalis R; Gonzales NR; Schlom J
    Methods; 2005 May; 36(1):25-34. PubMed ID: 15848072
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of human germline genes in a CDR homology-based approach to antibody humanization.
    Hwang WY; Almagro JC; Buss TN; Tan P; Foote J
    Methods; 2005 May; 36(1):35-42. PubMed ID: 15848073
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SDR grafting of a murine antibody using multiple human germline templates to minimize its immunogenicity.
    Gonzales NR; Padlan EA; De Pascalis R; Schuck P; Schlom J; Kashmiri SV
    Mol Immunol; 2004 Jul; 41(9):863-72. PubMed ID: 15261458
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structural mimicry of CD4 by a cross-reactive HIV-1 neutralizing antibody with CDR-H2 and H3 containing unique motifs.
    Prabakaran P; Gan J; Wu YQ; Zhang MY; Dimitrov DS; Ji X
    J Mol Biol; 2006 Mar; 357(1):82-99. PubMed ID: 16426633
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional selection of protease inhibitory antibodies.
    Lopez T; Mustafa Z; Chen C; Lee KB; Ramirez A; Benitez C; Luo X; Ji RR; Ge X
    Proc Natl Acad Sci U S A; 2019 Aug; 116(33):16314-16319. PubMed ID: 31363054
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug-like antibodies with high affinity, diversity and developability directly from next-generation antibody libraries.
    Azevedo Reis Teixeira A; Erasmus MF; D'Angelo S; Naranjo L; Ferrara F; Leal-Lopes C; Durrant O; Galmiche C; Morelli A; Scott-Tucker A; Bradbury ARM
    MAbs; 2021; 13(1):1980942. PubMed ID: 34850665
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protease Inhibition Mechanism of Camelid-like Synthetic Human Antibodies.
    Nam DH; Lee KB; Kruchowy E; Pham H; Ge X
    Biochemistry; 2020 Oct; 59(40):3802-3812. PubMed ID: 32997500
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.